Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Ayse Nur, Oktay"'
Autor:
Ayse Nur Oktay, James E. Polli
Publikováno v:
Pharmaceutics, Vol 16, Iss 11, p 1373 (2024)
Background/Objectives: Drug–polymer interactions and miscibility promote the formation and performance of amorphous solid dispersions (ASDs) of poorly soluble drugs for improved oral bioavailability. The objective of this study was to employ drug
Externí odkaz:
https://doaj.org/article/e4235aaf1978471da1a757ce8b8438a7
Publikováno v:
Pharmaceutical Research. 38:991-1009
Purpose The objective of this study was to optimize the Flurbiprofen (FB) nanosuspension (NS) based gel and to investigate the in vitro release, ex vivo permeation, the plasma concentration-time profile and pharmacokinetic parameters. Methods FB-NSs
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eddff55a204e897240ed5217b5754005
https://doi.org/10.1007/s11095-021-03060-6
https://doi.org/10.1007/s11095-021-03060-6
Publikováno v:
Journal of Drug Delivery Science and Technology. 79:104012
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c3fa99a7339f30680035071599d31e36
https://doi.org/10.1016/j.jddst.2022.104012
https://doi.org/10.1016/j.jddst.2022.104012
Autor:
Ayse, Nur Oktay, James E, Polli
Publikováno v:
International Journal of Pharmaceutics. 624:122015
Etravirine is an antiviral whose oral absorption is limited by low solubility/dissolution. The objective was to predict and compare etravirine's surfactant-mediated dissolution into polyoxyethylene-10 lauryl ether (POE) and FeSSIF-V2, including the c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::526f3d46185c36f9308195019ea1d72c
https://doi.org/10.1016/j.ijpharm.2022.122015
https://doi.org/10.1016/j.ijpharm.2022.122015
The objective of this study was to develop dermal nanosuspension (NS) based gel formulation of etodolac (ETD).Etodolac nanosuspension (ETD-NS) was prepared by wet milling method and dispersed in hy...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6c377f046ff9af6e13ec9074d5df19b0
https://avesis.gazi.edu.tr/publication/details/68eb884e-52bf-49bf-943a-17d34f1cd462/oai
https://avesis.gazi.edu.tr/publication/details/68eb884e-52bf-49bf-943a-17d34f1cd462/oai
Publikováno v:
Journal of microencapsulation. 38(4)
The objective of this study was to develop dermal nanosuspension (NS) based gel formulation of etodolac (ETD).Etodolac nanosuspension (ETD-NS) was prepared by wet milling method and dispersed in hydroxypropyl methylcellulose (NS-HPMC) or hydroxyethyl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::97acab04b3647df18cebf4dff38ac0b8
https://pubmed.ncbi.nlm.nih.gov/33752553
https://pubmed.ncbi.nlm.nih.gov/33752553
Autor:
İsmayil Mirzafarli, Habib Ahmad Esmat, Kevin Scott Jellis-Johnson, AYSE NUR OKTAY ALFATLI, ÖZGE ASLAN
Publikováno v:
Eur J Breast Health
Lupus mastitis (LM) is a rare presentation of lupus panniculitis (LP) that usually affects women of childbearing age and may mimic malignancy. The condition is recurrent and progresses along with the underlying disease. Breast pathology that may be a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::787c9d23679d027d3997a2a08d2c3c38
https://pubmed.ncbi.nlm.nih.gov/35059586
https://pubmed.ncbi.nlm.nih.gov/35059586
Flurbiprofen (FB) is an analgesic and anti-inflammatory drug, but its low water solubility (BCS Class II) limits its dermal bioavailability. The aim of this study is to develop a FB nanosuspension (NS) based gel and to evaluate its analgesic and anti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0988670dd28cf578f2f1be876cfa7b10
https://avesis.gazi.edu.tr/publication/details/144af911-1e01-4270-97c3-0f14553fd667/oai
https://avesis.gazi.edu.tr/publication/details/144af911-1e01-4270-97c3-0f14553fd667/oai
Although flurbiprofen (FB), as one of non-steroidal anti-inflammatory drugs, has various pharmacological applications, it shows low dermal bioavailability due to its low water solubility. To overcome this solubility problem, FB nanosuspensions were d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8219f178b388e0347b2bac7bcc5f69cd
https://avesis.gazi.edu.tr/publication/details/f7bdfb2b-1c81-4c19-895f-481189e23af5/oai
https://avesis.gazi.edu.tr/publication/details/f7bdfb2b-1c81-4c19-895f-481189e23af5/oai
Publikováno v:
Pharmaceutical development and technology. 24(10)
Flurbiprofen (FB) is an effective nonsteroidal anti-inflammatory and BCS class II drug and its poor solubility plays a critical role in limiting its bioavailability. Nanosuspensions can be defined as nanosized colloidal dispersions of drug particles
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a185fe51bdefd61b6265c9f616c0e554
https://pubmed.ncbi.nlm.nih.gov/31535942
https://pubmed.ncbi.nlm.nih.gov/31535942